Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

Live Events

Phoenix Roadshow 2025 – Copenhagen

October 7, 2025
Conference

CDISC US 2025

October 13 - 14, 2025
Conference

ACoP 2025

October 18 - 21, 2025

All late clinical resources

Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Best Practices in Clinical Pharmacology Gap Analysis

Certara Services, Clinical Pharmacology, Modeling and Simulation, Blog

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage

What is a Loading Dose?

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

Biogen Transforms Study Metadata Management with Certara’s Metadata Repository

Certara Products - Pinnacle 21, Data Standards, Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Certara Services, Clinical Trials, Drug Development, Project Management, Case Study

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

Certara IQ™: The Scalable AI-Powered QSP Software

Modeling and Simulation - QSP, Webinar

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Certara Products - Pinnacle 21, Data Standards, SDTM, Blog

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Biologics, Certara Products - Simcyp, Modeling and Simulation - QSP, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.